nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—MAPK Cascade—MAP2—age related macular degeneration	0.0604	0.0604	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.0274	0.0274	CbGpPWpGaD
Irbesartan—JUN—IL1-mediated signaling events—SQSTM1—age related macular degeneration	0.0264	0.0264	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—COL10A1—age related macular degeneration	0.0242	0.0242	CbGpPWpGaD
Irbesartan—CYP2D6—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0223	0.0223	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—TNFRSF10A—age related macular degeneration	0.0206	0.0206	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—TGFBR1—age related macular degeneration	0.0201	0.0201	CbGpPWpGaD
Irbesartan—CYP1A2—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0189	0.0189	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—SQSTM1—age related macular degeneration	0.018	0.018	CbGpPWpGaD
Irbesartan—JUN—RANKL/RANK Signaling Pathway—SQSTM1—age related macular degeneration	0.018	0.018	CbGpPWpGaD
Irbesartan—PTGS1—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0177	0.0177	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.0175	0.0175	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—RHO—age related macular degeneration	0.0157	0.0157	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.0157	0.0157	CbGpPWpGaD
Irbesartan—JUN—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.0154	0.0154	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.015	0.015	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—TNFRSF10A—age related macular degeneration	0.0146	0.0146	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.0137	0.0137	CbGpPWpGaD
Irbesartan—JUN—IL6-mediated signaling events—CRP—age related macular degeneration	0.0123	0.0123	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—age related macular degeneration	0.0123	0.0123	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.0118	0.0118	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—C3—age related macular degeneration	0.0114	0.0114	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—RHO—age related macular degeneration	0.0114	0.0114	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.0111	0.0111	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—SQSTM1—age related macular degeneration	0.0107	0.0107	CbGpPWpGaD
Irbesartan—UGT1A3—NRF2 pathway—SQSTM1—age related macular degeneration	0.0102	0.0102	CbGpPWpGaD
Irbesartan—JUN—Validated nuclear estrogen receptor alpha network—C3—age related macular degeneration	0.0101	0.0101	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TGFBR1—age related macular degeneration	0.00984	0.00984	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—RHO—age related macular degeneration	0.00895	0.00895	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—CCL2—age related macular degeneration	0.00893	0.00893	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—TGFBR1—age related macular degeneration	0.00884	0.00884	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—SQSTM1—age related macular degeneration	0.00856	0.00856	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.00832	0.00832	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00815	0.00815	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.00811	0.00811	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—CD36—age related macular degeneration	0.00785	0.00785	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—CST3—age related macular degeneration	0.00783	0.00783	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—C9—age related macular degeneration	0.00768	0.00768	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—CCL2—age related macular degeneration	0.00737	0.00737	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00732	0.00732	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—C3—age related macular degeneration	0.00722	0.00722	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—TLR4—age related macular degeneration	0.00678	0.00678	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—CD36—age related macular degeneration	0.00677	0.00677	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CFI—age related macular degeneration	0.00666	0.00666	CbGpPWpGaD
Irbesartan—CYP2D6—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00657	0.00657	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—TLR4—age related macular degeneration	0.00651	0.00651	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—RHO—age related macular degeneration	0.00645	0.00645	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—CD36—age related macular degeneration	0.00637	0.00637	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—TLR4—age related macular degeneration	0.00635	0.00635	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CFHR3—age related macular degeneration	0.00619	0.00619	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—CCL2—age related macular degeneration	0.00592	0.00592	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—RHO—age related macular degeneration	0.00586	0.00586	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—TLR4—age related macular degeneration	0.00585	0.00585	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—VEGFA—age related macular degeneration	0.00575	0.00575	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—CD36—age related macular degeneration	0.00567	0.00567	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—C3—age related macular degeneration	0.00567	0.00567	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CCL2—age related macular degeneration	0.00565	0.00565	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RDH8—age related macular degeneration	0.00564	0.00564	CbGpPWpGaD
Irbesartan—CYP1A2—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00556	0.00556	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—C2—age related macular degeneration	0.00552	0.00552	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—TLR4—age related macular degeneration	0.0055	0.0055	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00542	0.00542	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00521	0.00521	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—RHO—age related macular degeneration	0.00506	0.00506	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TLR4—age related macular degeneration	0.00496	0.00496	CbGpPWpGaD
Irbesartan—JUN—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00496	0.00496	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RPE65—age related macular degeneration	0.00493	0.00493	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NMNAT1—age related macular degeneration	0.0049	0.0049	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—TLR4—age related macular degeneration	0.0049	0.0049	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00485	0.00485	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CFH—age related macular degeneration	0.00462	0.00462	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—RHO—age related macular degeneration	0.0046	0.0046	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CFB—age related macular degeneration	0.00448	0.00448	CbGpPWpGaD
Irbesartan—JUN—Immune System—C9—age related macular degeneration	0.00447	0.00447	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CCL2—age related macular degeneration	0.00444	0.00444	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RDH8—age related macular degeneration	0.00443	0.00443	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00436	0.00436	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ELOVL4—age related macular degeneration	0.00429	0.00429	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00428	0.00428	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ABCA4—age related macular degeneration	0.00398	0.00398	CbGpPWpGaD
Irbesartan—JUN—Immune System—CFI—age related macular degeneration	0.00388	0.00388	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RPE65—age related macular degeneration	0.00387	0.00387	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—KDR—age related macular degeneration	0.00386	0.00386	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0038	0.0038	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00379	0.00379	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—C3—age related macular degeneration	0.00369	0.00369	CbGpPWpGaD
Irbesartan—JUN—Immune System—CFHR3—age related macular degeneration	0.00361	0.00361	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.0035	0.0035	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RHO—age related macular degeneration	0.00346	0.00346	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—SLC16A8—age related macular degeneration	0.00346	0.00346	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RDH8—age related macular degeneration	0.00331	0.00331	CbGpPWpGaD
Irbesartan—JUN—Immune System—C2—age related macular degeneration	0.00321	0.00321	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ABCA4—age related macular degeneration	0.00312	0.00312	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00298	0.00298	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—C3—age related macular degeneration	0.0029	0.0029	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RPE65—age related macular degeneration	0.00289	0.00289	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CCL2—age related macular degeneration	0.00289	0.00289	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00285	0.00285	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NMNAT1—age related macular degeneration	0.00276	0.00276	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RHO—age related macular degeneration	0.00271	0.00271	CbGpPWpGaD
Irbesartan—JUN—Immune System—CFH—age related macular degeneration	0.00269	0.00269	CbGpPWpGaD
Irbesartan—JUN—Immune System—CFB—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—VEGFA—age related macular degeneration	0.00256	0.00256	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00249	0.00249	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00244	0.00244	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ELOVL4—age related macular degeneration	0.00241	0.00241	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ABCA4—age related macular degeneration	0.00233	0.00233	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CCL2—age related macular degeneration	0.00227	0.00227	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00224	0.00224	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00216	0.00216	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—VEGFA—age related macular degeneration	0.00213	0.00213	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00212	0.00212	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—C3—age related macular degeneration	0.00209	0.00209	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RHO—age related macular degeneration	0.00203	0.00203	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SLC16A8—age related macular degeneration	0.00195	0.00195	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFBR1—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—C3—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD36—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.00178	0.00178	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—LIPC—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SQSTM1—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—C3—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CETP—age related macular degeneration	0.00171	0.00171	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CRP—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—C3—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—VEGFA—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Irbesartan—JUN—Immune System—SQSTM1—age related macular degeneration	0.0016	0.0016	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TLR4—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFBR1—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—C3—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCL2—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SQSTM1—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCL2—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFBR1—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—C3—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD36—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOE—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SQSTM1—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CD36—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—KDR—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Irbesartan—JUN—Immune System—C3—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—LIPC—age related macular degeneration	0.000996	0.000996	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00097	0.00097	CbGpPWpGaD
Irbesartan—JUN—Immune System—CRP—age related macular degeneration	0.000965	0.000965	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CETP—age related macular degeneration	0.000961	0.000961	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000958	0.000958	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR4—age related macular degeneration	0.000925	0.000925	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOE—age related macular degeneration	0.000905	0.000905	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—C3—age related macular degeneration	0.000878	0.000878	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL2—age related macular degeneration	0.000875	0.000875	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000874	0.000874	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000838	0.000838	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000837	0.000837	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOE—age related macular degeneration	0.000817	0.000817	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—KDR—age related macular degeneration	0.000801	0.000801	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000739	0.000739	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL2—age related macular degeneration	0.000687	0.000687	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000682	0.000682	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000675	0.000675	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—C3—age related macular degeneration	0.000656	0.000656	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.000644	0.000644	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000621	0.000621	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—age related macular degeneration	0.00061	0.00061	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000602	0.000602	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KDR—age related macular degeneration	0.000598	0.000598	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000583	0.000583	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CD36—age related macular degeneration	0.000578	0.000578	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VEGFA—age related macular degeneration	0.000562	0.000562	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000528	0.000528	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000524	0.000524	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000514	0.000514	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL2—age related macular degeneration	0.000513	0.000513	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CETP—age related macular degeneration	0.00051	0.00051	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—age related macular degeneration	0.00051	0.00051	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000505	0.000505	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000448	0.000448	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VEGFA—age related macular degeneration	0.000441	0.000441	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000432	0.000432	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CD36—age related macular degeneration	0.000373	0.000373	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000345	0.000345	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000333	0.000333	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VEGFA—age related macular degeneration	0.000329	0.000329	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—age related macular degeneration	0.000329	0.000329	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000306	0.000306	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000304	0.000304	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—age related macular degeneration	0.00027	0.00027	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000268	0.000268	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CD36—age related macular degeneration	0.00026	0.00026	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000229	0.000229	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CD36—age related macular degeneration	0.0002	0.0002	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000177	0.000177	CbGpPWpGaD
